Featured Article
National Academies of Sciences Call for Fundamental Changes in FDA Opioid Approvals
National Academies of Sciences Call for Fundamental Changes in FDA Opioid Approvals

It will take years of sustained, coordinated efforts to "contain and reverse" the prescription and illicit opioids epidemic, says a new, far-reaching report to the Food and Drug Administration from the National Academies of Sciences, Engineering, and Medicine. Contrary to ...

Read More

Blog posts in October

  • Deadly Fentanyl: 18 Cops Survive Exposure During Raid But 12-Year-Old At Birthday Sleepover Not So Lucky

    The headline above is about two separate events – a SWAT raid on a drug house and a kids’ birthday sleepover – not a single event. But it easily could ...

    View More
  • Health Officials and Docs Petition FDA to Take High-Dose Opioids Off Market

    A group of public health officials and doctors have filed a "Citizen Petition" with the Food and Drug Administration (FDA) asking the agency to remove ...

    View More
  • More adolescents arriving in ERs for opioid abuse; risk of addiction averages 50 times higher for youths after surgery

    A study of nearly 90,000 pediatric patients, ages 13 to 21 years, has found that new, persistent opioid use following surgery “may represent a ...

    View More
  • Endo Pharma agrees to pull Opana ER from market

    Endo Pharmaceuticals has agreed to pull Opana ER from the U.S. market, several weeks after being asked to do so by the FDA. The abuse-deterrent ...

    View More
  • More than half of all opioid prescriptions are written for mental health patients

    If you or someone you care for is being treated for anxiety, depression or some other mental health disorder, and are taking opioids to treat a ...

    View More

Start Your New Path to Sobriety Today!

    • Please enter your name.
    • This isn't a valid phone number.
    • Please enter your email address.
      This isn't a valid email address.
    • Please make a selection.
    • Please enter a message.